Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “GLIOBLASTOMA MULTIFORME”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04801147
What this trial is testing

Immunotherapy With Autologous Tumor Lysate-Loaded Dendritic Cells In Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Glioblastoma
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta 76
Large-scale testing (Phase 3)Study completedNCT03722355
What this trial is testing

Hyperfractionated RT With BCNU Versus Conventional RT With BCNU for Supratentorial Malignant Glioma

Who this might be right for
GliomaGlioblastoma MultiformeAstrocytoma
Radiation Therapy Oncology Group 712
Early research (Phase 1)Active Not RecruitingNCT03587038
What this trial is testing

OKN-007 in Combination With Adjuvant Temozolomide Chemoradiotherapy for Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma
University of Oklahoma 27
Testing effectiveness (Phase 2)Ended earlyNCT03600467
What this trial is testing

Activity of Seviteronel in Patients With Androgen Receptor (AR)-Positive Glioblastoma

Who this might be right for
Solid TumorAndrogen Receptor Gene Overexpression
St Vincent's Hospital, Sydney 4
Early research (Phase 1)Study completedNCT04968366
What this trial is testing

Safety & Efficacy of DC Vaccine and TMZ for the Treatment of Newly-diagnosed Glioblastoma After Surgery

Who this might be right for
Glioblastoma Multiforme of Brain
Beijing Tiantan Hospital 11
Large-scale testing (Phase 3)Looking for participantsNCT05902169
What this trial is testing

Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM

Who this might be right for
GlioblastomaRecurrent GlioblastomaGBM
CarThera 560
Testing effectiveness (Phase 2)Study completedNCT03310372
What this trial is testing

Concomitant Association of Ultrafractionated Brain Irradiation - Temozolomide in Inoperable Primary Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
Central Hospital, Nancy, France 46
Not applicableLooking for participantsNCT07111195
What this trial is testing

Feasibility of ONCOhabitats for Surgical and Treatment Planning in IDH-Wildtype Glioblastoma (SINUE)

Who this might be right for
Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype
Juan M Garcia-Gomez 140
Not applicableActive Not RecruitingNCT02375841
What this trial is testing

Coping With Glioblastoma: A Study of Communication Between Physicians, Patients, and Caregivers

Who this might be right for
Brain CancerGlioblastoma
Memorial Sloan Kettering Cancer Center 309
Testing effectiveness (Phase 2)UnknownNCT02928575
What this trial is testing

Combining Sunitinib, Temozolomide and Radiation to Treat Patients Diagnosed With Glioblastoma

Who this might be right for
Glioblastoma Multiforme
Bassam Abdulkarim 45
Early research (Phase 1)Study completedNCT00120939
What this trial is testing

Study of Motexafin Gadolinium and Docetaxel for Advanced Cancer

Who this might be right for
Breast NeoplasmsOvarian NeoplasmsProstatic Neoplasms+2 more
Pharmacyclics LLC. 25
Testing effectiveness (Phase 2)Ended earlyNCT01122901
What this trial is testing

Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Recurrent or Progressive Glioblastoma

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma+1 more
National Cancer Institute (NCI) 47
Not applicableLooking for participantsNCT04047264
What this trial is testing

Feasibility of Intra- and Post-operative Microdialysis During Neurosurgery for Central Nervous System Lesions

Who this might be right for
GliomaGlioblastomaMetastatic Malignant Neoplasm in the Brain
Mayo Clinic 100
Not applicableStudy completedNCT01604590
What this trial is testing

Imaging Biomarkers of Tissue Microstructure and Vasculature as Predictors of Glioblastoma Multiforme

Who this might be right for
Glioblastoma
Medical University of South Carolina 13
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07715097
What this trial is testing

Survivin-Targeted Dendritic Cell (DC) Cell Injection for Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma
Beijing Tricision Biotherapeutics Inc 30
Early research (Phase 1)Ended earlyNCT00516282
What this trial is testing

VNP40101M and Temozolomide in Treating Patients With Progressive or Relapsed Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Northwestern University 14
Testing effectiveness (Phase 2)Study completedNCT02805179
What this trial is testing

High-Dose Chemoradiation Using Biologically-Based Target Volume Definition in Patients With Glioblastoma

Who this might be right for
Glioma
University of Michigan Rogel Cancer Center 26
Post-approval studies (Phase 4)Study completedNCT00686725
What this trial is testing

Standard Temodal (Temozolomide) Regimen Versus Standard Regimen Plus Early Postsurgery Temodal for Newly Diagnosed Glioblastoma Multiforme (Study P05572)

Who this might be right for
Glioblastoma
Merck Sharp & Dohme LLC 99
Not applicableLooking for participantsNCT07144735
What this trial is testing

Allogeneic γδT Cells in Glioblastoma

Who this might be right for
Glioblastoma (GBM)Glioblastoma Multiforme (GBM)
Peking University Third Hospital 18
Early research (Phase 1)Study completedNCT00002824
What this trial is testing

Gene Therapy in Treating Patients With Primary Brain Tumors

Who this might be right for
Brain and Central Nervous System Tumors
Abramson Cancer Center at Penn Medicine
Next Page